240 related articles for article (PubMed ID: 32283653)
1. Role of microRNAs in Venous Thromboembolism.
Morelli VM; Brækkan SK; Hansen JB
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283653
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism.
Anijs RJS; Nguyen YN; Cannegieter SC; Versteeg HH; Buijs JT
J Thromb Haemost; 2023 Jan; 21(1):7-17. PubMed ID: 36695398
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals.
Starikova I; Jamaly S; Sorrentino A; Blondal T; Latysheva N; Sovershaev M; Hansen JB
Thromb Res; 2015 Sep; 136(3):566-72. PubMed ID: 26235746
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in venous thrombo-embolism.
Hembrom AA; Srivastava S; Garg I; Kumar B
Clin Chim Acta; 2020 May; 504():66-72. PubMed ID: 32017924
[TBL] [Abstract][Full Text] [Related]
5. The Role of MicroRNAs in Thrombosis.
Yapijakis C
Adv Exp Med Biol; 2021; 1339():409-414. PubMed ID: 35023133
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated thrombosis: What about microRNAs targeting the tissue factor coagulation pathway?
Tavares V; Neto BV; Marques IS; Assis J; Pereira D; Medeiros R
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189053. PubMed ID: 38092078
[TBL] [Abstract][Full Text] [Related]
7. Small RNA Sequencing Reveals Exosomal miRNAs as Unique Feature Markers in Unprovoked Venous Thromboembolism.
Fang N; Lai Z; Xu R; Huang P; Ye G; Lu W; Mo W; Zhang P
Acta Haematol; 2022; 145(5):505-516. PubMed ID: 35439757
[TBL] [Abstract][Full Text] [Related]
8. MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study.
Rossetti P; Goldoni M; Pengo V; Vescovini R; Mozzoni P; Tassoni MI; Lombardi M; Rubino P; Bernuzzi G; Verzicco I; Manotti C; Quintavalla R
Semin Thromb Hemost; 2021 Nov; 47(8):982-991. PubMed ID: 34243207
[TBL] [Abstract][Full Text] [Related]
9. Association of recurrent venous thromboembolism and circulating microRNAs.
Wang X; Sundquist K; Svensson PJ; Rastkhani H; Palmér K; Memon AA; Sundquist J; Zöller B
Clin Epigenetics; 2019 Feb; 11(1):28. PubMed ID: 30760335
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs predict recurrence and death following venous thromboembolism.
Ten Cate V; Rapp S; Schulz A; Pallares Robles A; Jurk K; Koeck T; Espinola-Klein C; Halank M; Seyfarth HJ; Beutel ME; Schuster AK; Marini F; Hobohm L; Lankeit M; Lackner KJ; Ruf W; Münzel T; Andrade-Navarro MA; Prochaska JH; Konstantinides SV; Wild PS
J Thromb Haemost; 2023 Oct; 21(10):2797-2810. PubMed ID: 37481073
[TBL] [Abstract][Full Text] [Related]
11. The plasma miRNome and venous thromboembolism in high-grade glioma: miRNA Sequencing of a nested case-control cohort.
Erhart F; Widhalm G; Kiesel B; Hackl M; Diendorfer A; Preusser M; Rössler K; Thaler J; Pabinger I; Ay C; Riedl J
J Cell Mol Med; 2024 Apr; 28(8):e18149. PubMed ID: 38613361
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of circulating microRNAs for venous thromboembolism diagnosis: A systematic review and diagnostic meta-analysis.
Xiang Q; Zhang HX; Wang Z; Liu ZY; Xie QF; Hu K; Zhang Z; Mu GY; Ma LY; Jiang J; Cui YM
Thromb Res; 2019 Sep; 181():127-134. PubMed ID: 31401416
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome.
Audu CO; Gordon AE; Obi AT; Wakefield TW; Henke PK
J Vasc Surg Venous Lymphat Disord; 2020 Mar; 8(2):299-305. PubMed ID: 32067731
[TBL] [Abstract][Full Text] [Related]
15. Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies.
Khorana AA; Weitz JI
Thromb Haemost; 2018 May; 118(S 01):S23-S33. PubMed ID: 29566417
[TBL] [Abstract][Full Text] [Related]
16. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Ay C; Pabinger I
Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-145 Impedes Thrombus Formation via Targeting Tissue Factor in Venous Thrombosis.
Sahu A; Jha PK; Prabhakar A; Singh HD; Gupta N; Chatterjee T; Tyagi T; Sharma S; Kumari B; Singh S; Nair V; Goel S; Ashraf MZ
EBioMedicine; 2017 Dec; 26():175-186. PubMed ID: 29217135
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment.
Antic D; Jelicic J; Vukovic V; Nikolovski S; Mihaljevic B
Blood Rev; 2018 Mar; 32(2):144-158. PubMed ID: 29126566
[TBL] [Abstract][Full Text] [Related]
20. Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: A new challenge for personalized therapy.
Benincasa G; Costa D; Infante T; Lucchese R; Donatelli F; Napoli C
Thromb Res; 2019 May; 177():145-153. PubMed ID: 30903874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
